Literature DB >> 15111474

Gaps in the care of patients admitted to hospital with an exacerbation of chronic obstructive pulmonary disease.

Perry P Choi1, Anna Day, Edward Etchells.   

Abstract

BACKGROUND: Patients admitted to hospital because of an exacerbation of chronic obstructive pulmonary disease (COPD) are at high risk of adverse events. We evaluated the association between gaps in care and adverse events during the hospital stay and after discharge.
METHODS: We retrospectively reviewed the charts of 105 consecutive patients discharged from hospital between Jan. 1 and Dec. 31, 2001, with a diagnosis of COPD exacerbation. On the basis of published guidelines, prior studies and discussions with colleagues, we defined a care gap as having occurred if any of 9 important inpatient and 7 discharge-related processes of care did not take place correctly. Inpatient adverse events included worsening of condition after admission, transfer to a higher level of care, cardiac arrest and death. Discharge-related adverse events were defined as including readmission to the hospital, revisit to the emergency department or death within 30 days after discharge.
RESULTS: Of the 105 patients studied, 88 (84%) had at least 1 inpatient gap in care and 16 (15%) an inpatient adverse event; 2 of the 16 died. Patients who had an inpatient adverse event had more gaps in their care (2.0 v. 1.3 gaps, p = 0.004) and longer stays (16.4 v. 8.6 days, p = 0.007). There were 6 adverse events (frequency 38%) among the 16 patients with 3 or more gaps in their care, 6 adverse events (28%) among the 21 patients with 2 gaps, 1 adverse event (2%) among the 51 patients with 1 gap and 3 adverse events (18%) among the 17 patients with no gaps in their care (p = 0.001 for trend). Of the 103 patients discharged alive, 102 (99%) had at least 1 gap in discharge-related care, but we found no association between these gaps and adverse events within 30 days after discharge.
INTERPRETATION: Gaps in the inpatient care of patients with COPD exacerbation were common and were associated with inpatient adverse events. Gaps in discharge-related care were also common but were not associated with postdischarge adverse events.

Entities:  

Mesh:

Year:  2004        PMID: 15111474      PMCID: PMC395814          DOI: 10.1503/cmaj.1030713

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  22 in total

Review 1.  Prevention of venous thromboembolism.

Authors:  W H Geerts; J A Heit; G P Clagett; G F Pineo; C W Colwell; F A Anderson; H B Wheeler
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease.

Authors:  V Snow; S Lascher; C Mottur-Pilson
Journal:  Ann Intern Med       Date:  2001-04-03       Impact factor: 25.391

3.  Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease.

Authors:  I M Osman; D J Godden; J A Friend; J S Legge; J G Douglas
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

4.  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.

Authors: 
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

5.  Hospital re-admission in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  A C Lau; L Y Yam; E Poon
Journal:  Respir Med       Date:  2001-11       Impact factor: 3.415

Review 6.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

7.  Inhaler technique of outpatients in the home.

Authors:  D H Johnson; P Robart
Journal:  Respir Care       Date:  2000-10       Impact factor: 2.258

8.  Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease.

Authors:  D D Sin; J V Tu
Journal:  Am J Respir Crit Care Med       Date:  2001-08-15       Impact factor: 21.405

9.  Factors associated with referral of elderly individuals with cardiac and pulmonary disorders for home care services following hospital discharge.

Authors:  G L Narsavage; M D Naylor
Journal:  J Gerontol Nurs       Date:  2000-05       Impact factor: 1.254

10.  The impact of follow-up physician visits on emergency readmissions for patients with asthma and chronic obstructive pulmonary disease: a population-based study.

Authors:  Don D Sin; Neil R Bell; Lawrence W Svenson; S F Paul Man
Journal:  Am J Med       Date:  2002-02-01       Impact factor: 4.965

View more
  7 in total

1.  Gaps in the inpatient management of chronic obstructive pulmonary disease exacerbation and impact of an evidence-based order set.

Authors:  Abhijat Kitchlu; Tamer Abdelshaheed; Elizabeth Tullis; Samir Gupta
Journal:  Can Respir J       Date:  2015-04-17       Impact factor: 2.409

2.  Resource use study in COPD (RUSIC): a prospective study to quantify the effects of COPD exacerbations on health care resource use among COPD patients.

Authors:  J Mark FitzGerald; Jennifer M Haddon; Carole Bradly-Kennedy; Lisa Kuramoto; Gordon T Ford
Journal:  Can Respir J       Date:  2007-04       Impact factor: 2.409

3.  Magnesium Sulfate in Exacerbations of COPD in Patients Admitted to Internal Medicine Ward.

Authors:  Mehrdad Solooki; Mirmohamad Miri; Majid Mokhtari; Morteza Valai; Mohammad Sistanizad; Mehran Kouchek
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

4.  Quality of care of hospitalized internal medicine patients bedspaced to non-internal medicine inpatient units.

Authors:  Jessica Liu; Joshua Griesman; Rosane Nisenbaum; Chaim M Bell
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

5.  Which patients with advanced respiratory disease die in hospital? A 14-year population-based study of trends and associated factors.

Authors:  Irene J Higginson; Charles C Reilly; Sabrina Bajwah; Matthew Maddocks; Massimo Costantini; Wei Gao
Journal:  BMC Med       Date:  2017-02-01       Impact factor: 8.775

6.  Reproducibility and respiratory function correlates of exhaled breath fingerprint in chronic obstructive pulmonary disease.

Authors:  Raffaele Antonelli Incalzi; Giorgio Pennazza; Simone Scarlata; Marco Santonico; Massimo Petriaggi; Domenica Chiurco; Claudio Pedone; Arnaldo D'Amico
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

7.  Antibiotics used in the ambulatory management of acute COPD exacerbations.

Authors:  Marie-France Beauchesne; Marcel Julien; Louis-André Julien; Dominique Piquette; Amélie Forget; Manon Labrecque; Lucie Blais
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.